triheptanoin has been researched along with Absence Seizure Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auvin, S; Blair, S; Brandabur, M; Collins, A; Davis, R; De Vivo, D; Garcia-Cazorla, A; Horvath, R; Kay Koenig, M; Koutsoukos, T; Lacy, A; Miller, I; Saneto, RP; Scheffer, IE; Striano, P; Tzadok, M | 1 |
1 trial(s) available for triheptanoin and Absence Seizure Disorder
| Article | Year |
|---|---|
A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome.
Topics: Adolescent; Adult; Anticonvulsants; Carbohydrate Metabolism, Inborn Errors; Child; Double-Blind Method; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsy, Absence; Glucose Transporter Type 1; Humans; Monosaccharide Transport Proteins; Seizures; Treatment Outcome; Triglycerides | 2022 |